Announcement
Mavengity Expands into B2B Research
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the Article
Posted in the last 24 hours
Fresh from the desks
Wealth Management
Schwab Keeps Raising the Referral Floor Until the Program Has No Reason to Exist
Schwab raised its advisor-referral asset minimum to $5 million, the second hike in a year. The rising floor tracks how much client complexity Schwab's own AI-augmented advisors can now absorb in-house, and it is squeezing the independent firms that built growth strategies on the flow.
Clinical Trials
In a Duchenne Trial, the Smallest Decisions Carry the Biggest Weight
A parent and outcome-measure developer argues that rare disease trials are built from hundreds of tiny, unguided design choices, and the deramiocel dispute shows what happens when those choices, made once in the dark, are litigated years later.
Public Health
The Case for Eating Less Protein Comes From Bodies Whose Problem Is Not the One Older Humans Have
A new review argues cutting protein could slow aging based on 350 studies, mostly from mice and worms whose problem is excess. Nutrition scientists warn the advice is being taken up by older adults and GLP-1 users, whose problem is loss, not excess.
Mental Health
Where Muscle Dysmorphia Sits in the DSM Decides Who Gets Treated for It
A UCSF specialist wants muscle dysmorphia reclassified from an OCD-spectrum condition to an eating disorder in the next diagnostic manual. The science is genuinely contested, but the reclassification is really an argument about treatment access, coverage, and research funding.
Public Health
The Money That Outlasts Politics Has Politics of Its Own
The State Department just directed nearly $2 billion in global health funding to mostly Christian organizations. A far larger, invisible pool, the annual zakat given by Muslims worldwide, shows what durable capital looks like, and what it costs to control.
Health Tech
The Diagnostic Miracle That Sold the Medical Chatbot Is the Easiest Part of Its Job
A Stanford chart-search AI helped solve a cancer diagnosis six pathologists missed. That story sells the tool, but it's the least representative and least important reason hospitals should adopt one. The real case rests on unglamorous, monitored routine work.
Clinical Trials
An Open-Label Extension Describes Only the Patients Who Stayed in It
Capricor is submitting open-label extension data to rescue its Duchenne drug after an FDA advisory panel voted against it. The submission has a structural limit no additional data can fix, because an extension cannot supply the untreated comparison approval requires.
Pharma Supply Chain
In Cancer's Biggest Year, the Hard Problem Moves From Discovery to Production
Two of oncology's hardest problems fell within months of each other this year, a KRAS inhibitor for pancreatic cancer and a personalized mRNA vaccine for melanoma. Both drugs are made to order, and both show the field's bottleneck has shifted from science to manufacturing.
Banking Regulation
What "Material" Means in a Bank Exam Is a Fight Over Who Gets the Last Word
Regulators propose rewriting the CAMELS bank rating system around issues that present material financial risk, but leave "material" undefined. More than sixty comment letters reveal the fight is really about who holds examiner discretion.
B2B Research
Most Popular Research Articles
Intent Data
Intent Data Providers For B2B
Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.
Knowledge Management
Knowledge Management Solutions
One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.
MDR
Managed Detection And Response Services
Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.
MDR Europe
Managed Detection And Response Services In Europe
Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.
Manufacturing Tech
Manufacturing Technology Services
Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.
Market Intelligence
Market And Competitive Intelligence Platforms
Generative AI should have commoditized this category, and instead Forrester's criteria count kept climbing, because the moat was always licensed source access, not summarization.
Open Banking
Open Banking Intermediaries
Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.
Change Management
Organizational Change Management Services
Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.
PLM
Product Lifecycle Management Platforms For Discrete Manufacturers
Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.
Announcements
News from Mavengity
Announcement
James T. Joins Mavengity as a Medical Writer
With James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the Article
Browse by topic
Where would you like to start?
Every article on Mavengity is written by a dedicated topic desk and checked against current market practice.
Insurance
Home, auto, life, and health coverage, explained clearly and checked against the fine print.
Browse InsuranceMortgage
Rates, refinancing, and first-time buyer strategy, without the jargon lenders assume you already know.
Browse MortgagePersonal Finance
Budgeting, saving, and everyday money habits that compound. No get-rich-quick promises.
Browse Personal FinanceLegal
Contracts, consumer rights, and disputes, explained so you know where you stand.
Browse LegalHealthcare & Medical
Health coverage and medical billing, broken down so surprise bills are less likely to surprise you.
Browse HealthcareResearch
Gartner and Forrester categories for B2B, translated into plain-English analysis for buyers, not analyst-subscription holders.
Browse Research
Why Mavengity
Editorial standards you can check
Independently researched
We start from public rate filings, regulator guidance, and lender disclosures, not marketing copy.
Plain-English explanations
If a term needs a footnote, we explain it in the sentence instead of hiding it in the fine print.
Straight, not slanted
We flag trade-offs and blind spots, not just the upside, so you get the full picture before you decide.
Written for readers, not lenders
Mavengity is reader-supported and editorially independent from the products we cover.